• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高级别脑膜瘤术后放疗的疗效

Efficacy of postoperative radiotherapy for high grade meningiomas.

作者信息

Choi Yunseon, Lim Do Hoon, Jo Kyungil, Nam Do-Hyun, Seol Ho Jun, Lee Jung-Il

机构信息

Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50, Irwon-dong, Gangnam-gu, Seoul, 135-710, Korea.

出版信息

J Neurooncol. 2014 Sep;119(2):405-12. doi: 10.1007/s11060-014-1507-1. Epub 2014 Jun 26.

DOI:10.1007/s11060-014-1507-1
PMID:24965339
Abstract

The necessity of postoperative radiotherapy (PORT) for meningiomas remains contentious. Here, the role of PORT in patients who underwent surgical resection for WHO grade II and III meningiomas was assessed. The record of 114 patients with WHO grade II (n = 72) and III (n = 42) meningiomas treated at Samsung Medical Center between March 1995 and April 2013 were reviewed and classified according to the extent of surgical resection and implementation of PORT. Median follow-up was 55.9 months. Simpson grade (SG) I, II, III, and IV resections were achieved in 29, 56, 9 and 20 patients, respectively. The 5-year local control (LC) and overall survival rate was 65.8 and 84.2 %, respectively. Thirty patients (26.3 %) developed local failure and five patients (4.4 %) developed distant metastases. The extent of surgical resection (SG I-II vs. III-IV) was influenced by tumor location (orbital and skull base lesions vs. others, p = 0.001) and the surgeons' experience (>10 operations, p = 0.044). Extent of surgical resection was also associated with local failure, overall progression, and overall survival (p = 0.001, p < 0.001, and p < 0.001, respectively). PORT improved LC in patients with incomplete surgical resection (SG III-IV, p = 0.049). Complete resection (SG I-II) is an important prognostic factor for LC and survival, and the extent of surgical resection (SG I-II vs. III-IV) is influenced by tumor location. PORT could improve the LC in WHO grade II-III meningioma patients who underwent incomplete surgical resection (SG III-IV).

摘要

脑膜瘤术后放疗(PORT)的必要性仍存在争议。在此,评估了PORT在接受WHO二级和三级脑膜瘤手术切除患者中的作用。回顾了1995年3月至2013年4月在三星医疗中心接受治疗的114例WHO二级(n = 72)和三级(n = 42)脑膜瘤患者的记录,并根据手术切除范围和PORT的实施情况进行分类。中位随访时间为55.9个月。分别有29、56、9和20例患者实现了辛普森分级(SG)I、II、III和IV级切除。5年局部控制(LC)率和总生存率分别为65.8%和84.2%。30例患者(26.3%)出现局部复发,5例患者(4.4%)出现远处转移。手术切除范围(SG I-II级与III-IV级)受肿瘤位置(眼眶和颅底病变与其他部位,p = 0.001)和外科医生经验(>10次手术,p = 0.044)影响。手术切除范围还与局部复发、总体进展和总生存相关(分别为p = 0.001、p < 0.001和p < 0.001)。PORT改善了手术切除不完全患者(SG III-IV级)的LC(p = 0.049)。完全切除(SG I-II级)是LC和生存的重要预后因素,手术切除范围(SG I-II级与III-IV级)受肿瘤位置影响。PORT可改善接受手术切除不完全(SG III-IV级)的WHO二级至三级脑膜瘤患者的LC。

相似文献

1
Efficacy of postoperative radiotherapy for high grade meningiomas.高级别脑膜瘤术后放疗的疗效
J Neurooncol. 2014 Sep;119(2):405-12. doi: 10.1007/s11060-014-1507-1. Epub 2014 Jun 26.
2
Risk group-adapted adjuvant radiotherapy for WHO grade I and II skull base meningioma.基于危险度分级的颅底脑膜瘤(WHO 分级 I 级和 II 级)辅助放疗。
J Cancer Res Clin Oncol. 2019 May;145(5):1351-1360. doi: 10.1007/s00432-019-02891-6. Epub 2019 Apr 5.
3
Effect of dural detachment on long-term tumor control for meningiomas treated using Simpson grade IV resection.硬脑膜剥离对 Simpson 分级 IV 切除治疗脑膜瘤的长期肿瘤控制效果的影响。
J Neurosurg. 2013 Dec;119(6):1373-9. doi: 10.3171/2013.8.JNS13832. Epub 2013 Sep 20.
4
Prognostic Value of Ki-67 Labeling Index and Postoperative Radiotherapy in WHO Grade II Meningioma.Ki-67标记指数及术后放疗在世界卫生组织II级脑膜瘤中的预后价值
Am J Clin Oncol. 2018 Jan;41(1):18-23. doi: 10.1097/COC.0000000000000224.
5
The Simpson grading in meningioma surgery: does the tumor location influence the prognostic value?脑膜瘤手术中的辛普森分级:肿瘤位置会影响其预后价值吗?
J Neurooncol. 2017 Jul;133(3):641-651. doi: 10.1007/s11060-017-2481-1. Epub 2017 May 19.
6
Long-term surgical outcome and biological prognostic factors in patients with skull base meningiomas.颅底脑膜瘤患者的长期手术结果和生物学预后因素。
J Neurosurg. 2011 May;114(5):1278-87. doi: 10.3171/2010.11.JNS10701. Epub 2010 Dec 17.
7
Analysis of patterns of failure and appraisal of postoperative radiation field for grade II-III meningioma.分析 II-III 级脑膜瘤的失败模式并评估术后放射野。
J Neurooncol. 2019 Sep;144(2):333-341. doi: 10.1007/s11060-019-03232-w. Epub 2019 Jul 5.
8
The Simpson grading revisited: aggressive surgery and its place in modern meningioma management.辛普森分级再探讨:积极手术及其在现代脑膜瘤管理中的地位。
J Neurosurg. 2016 Sep;125(3):551-60. doi: 10.3171/2015.9.JNS15754. Epub 2016 Jan 29.
9
Impact of postoperative radiotherapy on recurrence of primary intracranial atypical meningiomas.术后放疗对原发性颅内非典型脑膜瘤复发的影响。
J Neurooncol. 2020 Jan;146(2):347-355. doi: 10.1007/s11060-019-03382-x. Epub 2020 Jan 3.
10
Skull base atypical meningioma: long term surgical outcome and prognostic factors.颅底非典型脑膜瘤:长期手术结果及预后因素
Clin Neurol Neurosurg. 2015 Jan;128:112-6. doi: 10.1016/j.clineuro.2014.11.009. Epub 2014 Nov 24.

引用本文的文献

1
A nomogram to predict cancer-specific mortality in adult patients with malignant meningioma: a competing risk analysis.预测成年恶性脑膜瘤患者癌症特异性死亡率的列线图:一项竞争风险分析
Discov Oncol. 2024 Aug 31;15(1):394. doi: 10.1007/s12672-024-01263-y.
2
Anaplastic Meningioma: Clinical Characteristics, Prognostic Factors and Survival Outcome.间变性脑膜瘤:临床特征、预后因素及生存结果
Brain Tumor Res Treat. 2022 Oct;10(4):244-254. doi: 10.14791/btrt.2022.0030.
3
An interpretable radiomics model to select patients for radiotherapy after surgery for WHO grade 2 meningiomas.

本文引用的文献

1
Controversies in radiotherapy for meningioma.脑膜瘤放射治疗的争议。
Clin Oncol (R Coll Radiol). 2014 Jan;26(1):51-64. doi: 10.1016/j.clon.2013.10.001. Epub 2013 Oct 24.
2
Radiation Treatment for WHO Grade II and III Meningiomas.世界卫生组织二级和三级脑膜瘤的放射治疗
Front Oncol. 2013 Sep 2;3:227. doi: 10.3389/fonc.2013.00227.
3
The role of adjuvant radiotherapy in atypical meningioma.辅助放疗在非典型脑膜瘤中的作用。
一种可解释的放射组学模型,用于选择手术后 WHO 分级 2 脑膜瘤患者进行放疗。
Radiat Oncol. 2022 Aug 22;17(1):147. doi: 10.1186/s13014-022-02090-7.
4
Prognostic Factors and Treatment Strategies for Elderly Patients with Malignant Meningioma: A SEER Population-Based Study.老年恶性脑膜瘤患者的预后因素及治疗策略:一项基于监测、流行病学和最终结果(SEER)数据库人群的研究
Front Oncol. 2022 May 13;12:913254. doi: 10.3389/fonc.2022.913254. eCollection 2022.
5
Alterations Predict Tumor Progression in High-Grade Meningiomas Following Adjuvant Radiotherapy.辅助放疗后高级别脑膜瘤的改变可预测肿瘤进展
Front Oncol. 2021 Oct 29;11:747592. doi: 10.3389/fonc.2021.747592. eCollection 2021.
6
Prognostic Model That Predicts Benefits of Adjuvant Radiotherapy in Patients With High Grade Meningioma.预测高级别脑膜瘤患者辅助放疗获益的预后模型。
Front Oncol. 2020 Nov 10;10:568079. doi: 10.3389/fonc.2020.568079. eCollection 2020.
7
Long-term outcomes of multimodality management for parasagittal meningiomas.矢状旁脑膜瘤的多模态治疗的长期结果。
J Neurooncol. 2020 Apr;147(2):441-450. doi: 10.1007/s11060-020-03440-9. Epub 2020 Feb 22.
8
Efficacy of adjuvant radiotherapy for atypical and anaplastic meningioma.辅助放疗对非典型性和间变性脑膜瘤的疗效。
Cancer Med. 2019 Jan;8(1):13-20. doi: 10.1002/cam4.1531.
9
Recurrence pattern analysis after [Ga]-DOTATATE-PET/CT -planned radiotherapy of high-grade meningiomas.[Ga]-DOTATATE-PET/CT 计划放疗后高级别脑膜瘤的复发模式分析。
Radiat Oncol. 2018 Jun 14;13(1):110. doi: 10.1186/s13014-018-1056-4.
10
Recent advances in managing/understanding meningioma.脑膜瘤管理/认识方面的最新进展
F1000Res. 2018 Apr 24;7. doi: 10.12688/f1000research.13674.1. eCollection 2018.
J Neurooncol. 2013 Nov;115(2):241-7. doi: 10.1007/s11060-013-1219-y. Epub 2013 Aug 15.
4
Quality assurance of radiotherapy in the ongoing EORTC 22042-26042 trial for atypical and malignant meningioma: results from the dummy runs and prospective individual case Reviews.在进行中的 EORTC 22042-26042 非典型性和恶性脑膜瘤试验中对放射治疗进行质量保证:模拟运行和前瞻性个别病例审查的结果。
Radiat Oncol. 2013 Jan 30;8:23. doi: 10.1186/1748-717X-8-23.
5
Radiotherapy for malignant tumors of the skull base.颅底恶性肿瘤的放射治疗。
Neurosurg Clin N Am. 2013 Jan;24(1):125-35. doi: 10.1016/j.nec.2012.08.011.
6
Significance of Simpson grading system in modern meningioma surgery: integration of the grade with MIB-1 labeling index as a key to predict the recurrence of WHO Grade I meningiomas.辛普森分级系统在现代脑膜瘤手术中的意义:将分级与 MIB-1 标记指数相结合,作为预测 WHO Ⅰ级脑膜瘤复发的关键。
J Neurosurg. 2012 Jul;117(1):121-8. doi: 10.3171/2012.3.JNS111945. Epub 2012 May 4.
7
Meningioma: review of the literature with emphasis on the approach to radiotherapy.脑膜瘤:文献复习,重点关注放疗方法。
Expert Rev Anticancer Ther. 2011 Nov;11(11):1749-58. doi: 10.1586/era.11.162.
8
Radiotherapy for atypical meningiomas.非典型脑膜瘤的放射治疗。
J Neurosurg. 2011 Oct;115(4):811-9. doi: 10.3171/2011.5.JNS11112. Epub 2011 Jun 24.
9
Fractionated stereotactic radiotherapy in patients with optic nerve sheath meningioma.分次立体定向放射治疗视神经鞘脑膜瘤。
Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):773-8. doi: 10.1016/j.ijrobp.2010.11.018. Epub 2011 Feb 6.
10
Opportunities for clinical research in meningioma.脑膜瘤的临床研究机会。
J Neurooncol. 2010 Sep;99(3):417-22. doi: 10.1007/s11060-010-0375-6. Epub 2010 Sep 11.